A Randomized Phase I Trial of Nanoparticle Albumin Bound Paclitaxel (Nab-paclitaxel, Abraxane) With or Without Mifepristone for Advanced Breast Cancer

Trial Profile

A Randomized Phase I Trial of Nanoparticle Albumin Bound Paclitaxel (Nab-paclitaxel, Abraxane) With or Without Mifepristone for Advanced Breast Cancer

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 03 Jan 2017

At a glance

  • Drugs Mifepristone (Primary) ; Paclitaxel (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Dec 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Jun 2017.
    • 24 Jun 2015 Planned End Date changed from 1 Nov 2015 to 1 Nov 2017 as reported by ClinicalTrials.gov.
    • 03 Mar 2014 According to ClinicalTrials.gov record, planned end date changed from 1 Jan 2015 to 1 Nov 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top